Traditional methods used to detect bacterial endotoxins—particularly the LAL (Limulus Amebocyte Lysate) test—present significant operational, financial, and logistical challenges that impact pharmaceutical manufacturers worldwide. From time-consuming processes and costly retests to supply chain vulnerabilities and regulatory complexity, endotoxin testing reduces efficiency in production and slows product delivery.
Download this poster from Veolia to learn more about five critical areas to consider when performing endotoxin testing, as well as solutions that address the operational, financial, and human factors that impact traditional endotoxin testing.